Zolopa 2013

Zolopa A, Sax P, DeJesus E, et al. A randomized double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus favirenz/emtricitabine/tenofovirdisoproxil fumarate for initial treatment of HIV-1 infection: Analysis of Week 96 results. J Acquir Immune Defic Syndr. 2013;63:96-100.
Type
Journal Article
Title
A randomized double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus favirenz/emtricitabine/tenofovirdisoproxil fumarate for initial treatment of HIV-1 infection: Analysis of Week 96 results
Source
J Acquir Immune Defic Syndr. 2013;63:96-100
1st Author
Zolopa AR
Authors
Zolopa AR
Sax PE
DeJesus E
Year
2013
Page(s)
96-100

Connect

Phone: 202-659-0699
Fax: 202-659-0976

Contact

AAHIVM National Office
1705 DeSales Street NW, Suite 700
Washington, D.C. 20036

About

The American Academy of HIV Medicine is a professional organization that supports the HIV practitioner and promotes accessible, quality care for all Americans living with HIV disease. Our membership of HIV practitioners and credentialed HIV Specialists™, HIV Experts™, and HIV Pharmacists™ provide direct care to the majority of HIV patients in the US.